Waters Corporation  

(Public, NYSE:WAT)   Watch this stock  
Find more results for WAT
+3.15 (2.72%)
Real-time:   10:44AM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 116.01 - 120.18
52 week 112.00 - 137.39
Open 116.73
Vol / Avg. 100,603.00/623,531.00
Mkt cap 9.91B
P/E 21.05
Div/yield     -
EPS 5.65
Shares 81.65M
Beta 0.87
Inst. own 97%
Apr 26, 2016
Q1 2016 Waters Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Feb 11, 2016
Waters Corp at Leerink Partners Global Healthcare Conference - 1:25PM EST - Add to calendar
Jan 26, 2016
Q4 2015 Waters Corp Earnings Release
Jan 26, 2016
Q4 2015 Waters Corp Earnings Call - Webcast
Jan 11, 2016
Waters Corp at JPMorgan Healthcare Conference
Nov 17, 2015
Waters Corp at Stifel Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 25.75% 22.97%
Operating margin 30.91% 27.78%
EBITD margin - 28.47%
Return on average assets 14.46% 11.53%
Return on average equity 30.09% 23.73%
Employees 6,200 -
CDP Score - 71 D


MILFORD, MA 01757-3604
United States - Map
+1-508-4782000 (Phone)
+1-508-8721990 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Waters Corporation (Waters) is an analytical instrument manufacturer. The Company designs, manufactures, distributes and services instrument systems, columns and other chemistry consumables that are integrated and used along with other analytical instruments. The Company has two segments: Waters Division and TA Division. The Waters Division’s products and services primarily consist of high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC), mass spectrometry (MS) and chemistry consumable products and related services. TA Division’s products and services primarily consist of thermal analysis, rheometry and calorimetry instrument systems and service sales. The Company’s products are used by pharmaceutical, life science, biochemical, industrial, nutritional safety, environmental, academic and governmental customers working in research and development, quality assurance and other laboratory applications.

Officers and directors

Douglas A. Berthiaume Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Christopher J. O'Connell President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Eugene G. Cassis Chief Financial Officer, Senior Vice President
Age: 58
Bio & Compensation  - Reuters
Arthur G. Caputo Executive Vice President, President - Waters Division
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark T. Beaudouin Senior Vice President, General Counsel, Secretary
Age: 60
Bio & Compensation  - Reuters
Elizabeth B. Rae Senior Vice President - Global Human Resources
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Thomas P. Salice Lead Independent Director
Age: 55
Bio & Compensation  - Reuters
Joshua Bekenstein Independent Director
Age: 56
Bio & Compensation  - Reuters
Michael Joseph Berendt Ph.D. Independent Director
Age: 66
Bio & Compensation  - Reuters
Edward W. Conard Independent Director
Age: 58
Bio & Compensation  - Reuters